Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Glycine decarboxylase deficiency–induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level
Raphaëlle Riché, Meijiang Liao, Izabella A. Pena, Kit-Yi Leung, Nathalie Lepage, Nicolas D.E. Greene, Kyriakie Sarafoglou, Lisa A. Schimmenti, Pierre Drapeau, Éric Samarut
Raphaëlle Riché, Meijiang Liao, Izabella A. Pena, Kit-Yi Leung, Nathalie Lepage, Nicolas D.E. Greene, Kyriakie Sarafoglou, Lisa A. Schimmenti, Pierre Drapeau, Éric Samarut
View: Text | PDF
Research Article Genetics Neuroscience

Glycine decarboxylase deficiency–induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level

  • Text
  • PDF
Abstract

Glycine encephalopathy (GE), or nonketotic hyperglycinemia (NKH), is a rare recessive genetic disease caused by defective glycine cleavage and characterized by increased accumulation of glycine in all tissues. Here, based on new case reports of GLDC loss-of-function mutations in GE patients, we aimed to generate a zebrafish model of severe GE in order to unravel the molecular mechanism of the disease. Using CRISPR/Cas9, we knocked out the gldc gene and showed that gldc–/– fish recapitulate GE on a molecular level and present a motor phenotype reminiscent of severe GE symptoms. The molecular characterization of gldc–/– mutants showed a broad metabolic disturbance affecting amino acids and neurotransmitters other than glycine, with lactic acidosis at stages preceding death. Although a transient imbalance was found in cell proliferation in the brain of gldc–/– zebrafish, the main brain networks were not affected, thus suggesting that GE pathogenicity is mainly due to metabolic defects. We confirmed that the gldc–/– hypotonic phenotype is due to NMDA and glycine receptor overactivation, and demonstrated that gldc–/– larvae depict exacerbated hyperglycinemia at these synapses. Remarkably, we were able to rescue the motor dysfunction of gldc–/– larvae by counterbalancing pharmacologically or genetically the level of glycine at the synapse.

Authors

Raphaëlle Riché, Meijiang Liao, Izabella A. Pena, Kit-Yi Leung, Nathalie Lepage, Nicolas D.E. Greene, Kyriakie Sarafoglou, Lisa A. Schimmenti, Pierre Drapeau, Éric Samarut

×

Figure 6

The main brain networks are not affected by gldc KO despite a transient decrease of proliferation in gldc–/– brain.

Options: View larger image (or click on image) Download as PowerPoint
The main brain networks are not affected by gldc KO despite a transient ...
(A) IHC against phospho–histone 3 (phospho-H3) labels proliferating cells in gldc–/– and gldc+/+ 3 dpf larvae. (B) IHC against acetylated tubulin (AC-TUBULIN) labeling axonal tracks did not reveal any gross morphological difference at 1 and 4 dpf between gldc–/– and gldc+/+ larvae. (C) The transgenic dlx5/6:GFP line was used to visualize GABAergic cells in gldc–/– and gldc+/+ 7-dpf larvae. (D) Using the vGluT2:RFP transgenic line to label the glutamatergic network did not reveal any gross morphological difference between gldc–/– and gldc+/+ 7-dpf larvae. (E) IHC against tyrosine hydroxylase (TH) labeling dopaminergic neurons did not reveal any gross morphological difference between gldc–/– and gldc+/+ at 5 dpf. (F) IHC against paravalbumin 7 (PAV7) labels Purkinje cells of the cerebellum on 5 dpf gldc–/– and gldc+/+ larvae. (G) IHC against VGLUT1 labeling granule cells of the cerebellum did not reveal any gross morphological difference between 5-dpf gldc–/– and gldc+/+ larvae. (H) Using the islet1:GFP transgenic line to label the branchiomotor neuron network did not reveal any gross morphological difference between gldc–/– and gldc+/+ 3-dpf larvae. (I) Quantification of the number of phospho-H3–positive (Ph3+) cells revealed a significant decrease in proliferating cells in gldc–/– compared with gldc+/+ larvae at 1 and 3 dpf (t test, respectively, **P = 0.0223 and *P = 0.014), but not 7 dpf. (J) Quantification of dlx5/6:GFP-positive cells did not reveal any difference between gldc–/– and gldc+/+ larvae. (K) Quantification of the number PAV7-positive cells did not reveal any difference between gldc–/– and gldc+/+. Boxes and whiskers represent minimum and maximum values, and a line shows the median value. Each dot corresponds to an individual biological replicate (n > 5).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts